ascopubs.org: Treatment patterns and survival outcomes in Klatskin tumors: A real-world analysis of the TriNetX network.
Treatment patterns and survival outcomes in Klatskin tumors: A real-world analysis of the TriNetX network.
Cholangiocarcinomas are malignant tumors that derive from cholangiocytes of small intrahepatic bile ducts or bile ductules (intrahepatic cholangiocarcinoma; ICC), or of large hilar or extrahepatic ...
Cholangiocarcinoma (CCA) is an uncommon malignant tumor arising from the biliary epithelium. The incidence increases with age and usually affects individuals in their 6th or 7th decade of life. Those ...
Cholangiocarcinoma, or bile duct cancer, occurs when a malignant (cancerous) tumor grows in one of the ducts that transport bile from the liver to the small intestine.
Bile Duct Cancer (Cholangiocarcinoma) Cholangiocarcinoma or bile duct cancer is a type of liver cancer that affects the bile ducts inside and outside the liver. These tumors account for one-third of all liver and biliary passage tumors. Conditions or diseases associated with bile duct tumors include: Gallstones – Which may cause persistent irritation of the ducts. Liver fluke (parasite ...
ascopubs.org: Biliary intervention combined with lenvatinib+ PD-1 inhibitor of Klatskin tumor complicated with malignant obstructive jaundice.
Biliary intervention combined with lenvatinib+ PD-1 inhibitor of Klatskin tumor complicated with malignant obstructive jaundice.
Comparative safety of futibatinib vs pemigatinib in metastatic cholangiocarcinoma: FAERS-based analysis. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium. This ...
Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma ...